// App-Quantinova.ai

223P : CIRCULATING TUMOR CELL (CTC) COUNT AND EXPRESSION OF PERK AND PAKT IN CTCS AS BIOMARKERS FOR SORAFENIB EFFICACY IN ADVANCED HEPATOCELLULAR CARCINOMA

Researchers

Presenter

  • J. LI

Principal Investigators

  • L. Shi

  • Y. Yang

  • M. Wu

  • Z. Yin

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • Phosphorylated-AKT

  • Phosphorylated-extracellular signal regulated kinase

  • Circulating tumor cells

Drug/Treatment

  • Sorafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved